Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome.
Flores-Blanco PJ, Cambronero-Sánchez F, Raposeiras-Roubin S, Abu-Assi E, Leithold G, Cobas-Paz R, Rodríguez Serrano AI, Calvo-Iglesias F, Valdés M, Januzzi JL, Iñiguez-Romo A, Manzano-Fernández S.
Flores-Blanco PJ, et al.
Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):538-544. doi: 10.1016/j.rec.2017.10.009. Epub 2017 Nov 14.
Rev Esp Cardiol (Engl Ed). 2018.
PMID: 29146484
English, Spanish.